How long does Respiratory have?

Any thoughts?

 

1.5 years max. Still no leadership. Thinks STEM works. Like giving answers to test.

 

Downsizing again this 3rd quarter. Will eventually end up a small specialty force, or in the hands of a contract force.

 

P.O.S. company! I hope respiratory goes away by end of this year! They have way too many FLL’s drawing huge salaries who do nothing! FVPs who think they are smart but are out of touch! Too many reps trying to promote only 2 products. One rep per territory could cover both! I’d love to see karma bite some of these FLLs and FVPs in the ass!

 

! !. ! !

 

Love my part - time job here at GSK.

 

Nailed it!!!!

 

Respiratory goes contract 2020. Specialty is not safe. FRMs done in Q3, RBS Q4.

 

What's the out look for respiratory R and D?

 

You don’t know anything! You are just guessing!

 

Thought all R and D monies now going to oncology. Not sure what’s left in Respiratory. Think that’s a good sign of what’s going to happen.

 

By the end of 2019 respiratory WILL BE GONE. Put it in stone. Contract reps will be all that is left.

 

So when did you get canned?

 

The demise of respiratory was predicted by Axel Hoos. He actually spoke to Endpoints and described exactly what was to come. That was last year. Unfortunately not many people paid heed to his words.

"I don’t want to be inappropriate and step on some toes, but we have areas that have a higher probability of growth and areas with a lower probability of growth. Our respiratory franchise, for example, has been a driver for GSK R&D for a long time and we’ve been very successful with it … but it’s also pretty flat,” Hoos is quoted as saying. “There is not much growth to be expected. … This was a very successful business and continues to be — it’s just much harder to innovate in respiratory than it is to innovate in oncology.”

The next big thing at GlaxoSmithKline R&D is clearly oncology — respiratory can take a back seat now

 

Axel said that publicly and Hal denied that it was intended at a town hall in stockley. Shameful really. Still waiting for R and D portfolio review...they're taking too long over this

 

We are on our last breath!

 

It’s been over ever since we nailed Advair for mild asthma. $700 mill payday. Write Right?